• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
The UK practice of Anti-VEGF therapy for treatment of retinopathy of prematurity.英国抗血管内皮生长因子疗法治疗早产儿视网膜病变的实践
Eye (Lond). 2021 Sep;35(9):2451-2453. doi: 10.1038/s41433-021-01543-9. Epub 2021 Apr 20.
2
Intravitreal bevacizumab for retinopathy of prematurity: Considerations for informed consent.玻璃体内注射贝伐单抗治疗早产儿视网膜病变：知情同意的考量
Can J Ophthalmol. 2015 Dec;50(6):409-12. doi: 10.1016/j.jcjo.2015.10.004.
3
Ultra-low-dose anti-VEGF treatment in retinopathy of prematurity.
Eur J Ophthalmol. 2022 Jan;32(1):NP290. doi: 10.1177/1120672119868428. Epub 2019 Aug 5.
4
Fundus Pigmentation in the Diagnosis and Treatment of Retinopathy of Prematurity.眼底色素沉着在早产儿视网膜病变诊治中的应用
Ophthalmology. 2021 Aug;128(8):1242-1244. doi: 10.1016/j.ophtha.2020.12.024. Epub 2020 Dec 29.
5
The Use of Bevacizumab in the Treatment of Retinopathy of Prematurity.
Int Ophthalmol Clin. 2022 Jan 1;62(1):219-230. doi: 10.1097/IIO.0000000000000400.
6
Does Bevacizumab Alter Vascularization Potential in Retinopathy of Prematurity?贝伐单抗是否会改变早产儿视网膜病变的血管生成潜能？
Ophthalmology. 2016 Sep;123(9):2042-3. doi: 10.1016/j.ophtha.2016.04.024. Epub 2016 Jun 16.
7
Retinopathy of Prematurity: Evolving Treatment With Anti-Vascular Endothelial Growth Factor.早产儿视网膜病变：抗血管内皮生长因子的治疗进展。
Am J Ophthalmol. 2020 Oct;218:208-213. doi: 10.1016/j.ajo.2020.05.025. Epub 2020 May 23.
8
Reactivation of retinopathy of prematurity six years after intravitreal injection of bevacizumab.六年内眼内注射贝伐单抗后早产儿视网膜病变的再激活。
J AAPOS. 2023 Aug;27(4):236-239. doi: 10.1016/j.jaapos.2023.05.008. Epub 2023 Jul 13.
9
Bevacizumab for retinopathy of prematurity and neurodevelopment.
J AAPOS. 2024 Feb;28(1):103786. doi: 10.1016/j.jaapos.2023.08.018. Epub 2023 Nov 4.
10
Bevacizumab for retinopathy of prematurity and neurodevelopment.贝伐单抗用于早产儿视网膜病变及神经发育
J AAPOS. 2023 Feb;27(1):1-2. doi: 10.1016/j.jaapos.2023.01.002. Epub 2023 Jan 7.

引用本文的文献

1
Safety profile of anesthetic modalities during laser treatment for retinopathy of prematurity: a systematic review.早产儿视网膜病变激光治疗中不同麻醉方式的安全性：系统评价。
J Perinatol. 2023 Jun;43(6):685-693. doi: 10.1038/s41372-023-01622-7. Epub 2023 Jan 28.

本文引用的文献

1
Endophthalmitis in Retinopathy of Prematurity after Intravitreal Aflibercept Injection.玻璃体腔内注射阿柏西普后早产儿视网膜病变并发眼内炎
Case Rep Ophthalmol Med. 2020 Dec 21;2020:8861435. doi: 10.1155/2020/8861435. eCollection 2020.
2
Neurodevelopmental outcomes following bevacizumab treatment for retinopathy of prematurity: a systematic review and meta-analysis.早产儿视网膜病变应用贝伐单抗治疗后的神经发育结局：系统评价和荟萃分析。
J Perinatol. 2021 Jun;41(6):1225-1235. doi: 10.1038/s41372-020-00884-9. Epub 2020 Dec 8.
3
Neurodevelopmental Outcomes after Bevacizumab Treatment for Retinopathy of Prematurity: A Meta-analysis.早产儿视网膜病变应用贝伐单抗治疗后的神经发育结局：Meta 分析。
Ophthalmology. 2021 Jun;128(6):877-888. doi: 10.1016/j.ophtha.2020.11.012. Epub 2020 Nov 16.
4
Short-Term Changes in Intraocular Pressure After Intravitreal Injection of Bevacizumab for the Treatment of Retinopathy of Prematurity.玻璃体内注射贝伐单抗治疗早产儿视网膜病变后眼压的短期变化
Clin Ophthalmol. 2019 Dec 10;13:2445-2449. doi: 10.2147/OPTH.S229708. eCollection 2019.
5
Glaucoma following cataract surgery in the first 2 years of life: frequency, risk factors and outcomes from IoLunder2.2 岁以内儿童白内障术后青光眼：发病频率、危险因素及 IoLunder2 研究结果
Br J Ophthalmol. 2020 Jul;104(7):967-973. doi: 10.1136/bjophthalmol-2019-314804. Epub 2019 Oct 5.
6
Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial.雷珠单抗与激光治疗用于治疗极低出生体重早产儿视网膜病变（RAINBOW）：一项开放标签随机对照试验。
Lancet. 2019 Oct 26;394(10208):1551-1559. doi: 10.1016/S0140-6736(19)31344-3. Epub 2019 Sep 12.
7
Paediatric endophthalmitis: a UK retrospective study.小儿眼内炎：一项英国回顾性研究。
Eye (Lond). 2020 Mar;34(3):553-561. doi: 10.1038/s41433-019-0546-4. Epub 2019 Aug 12.
8
Post-Ranibizumab injection endophthalmitis in aggressive posterior retinopathy of prematurity.早产儿后部进展性视网膜病变经雷珠单抗注射后的眼内炎。
Indian J Ophthalmol. 2019 Jun;67(6):967-969. doi: 10.4103/ijo.IJO_884_17.
9
Special considerations for pediatric vitreoretinal surgery.小儿玻璃体视网膜手术的特殊注意事项。
Taiwan J Ophthalmol. 2018 Oct-Dec;8(4):237-242. doi: 10.4103/tjo.tjo_83_18.
10
Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.用于治疗早产儿视网膜病变的抗血管内皮生长因子（VEGF）药物。
Cochrane Database Syst Rev. 2018 Jan 8;1(1):CD009734. doi: 10.1002/14651858.CD009734.pub3.

The UK practice of Anti-VEGF therapy for treatment of retinopathy of prematurity.

作者信息

Ahmed Shahanaz B, Higham Aisling, Mulvihill Alan, Chan T K J, Adams Gill, Patel Chetan K

机构信息

Oxford Eye Hospital, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Royal Hospital for Children and Young People, NHS Lothian, Edinburgh, UK.

出版信息

Eye (Lond). 2021 Sep;35(9):2451-2453. doi: 10.1038/s41433-021-01543-9. Epub 2021 Apr 20.

DOI:10.1038/s41433-021-01543-9
PMID:33879853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8377112/
Abstract
摘要